Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 1998

View Archived Issues

Cell Therapeutics: Q3 1998 highlights

Vical: Q3 1998 highlights

Neurocrine Biosciences: Q3 1998 highlights

Contrast sonography with Echovist is safe and effective for assessing tubal patency

New LYMErix study results point to faster immunization

New compound described for the treatment of pregnancy-induced hypertension

Phytoanalgesic agent WS-1531 shows limited efficacy, good safety in treating back pain

Pexiganan acetate: a potent and broad-spectrum antibiotic with few resistance problems

Organogenesis completes patient enrollment in Apligraf diabetic foot ulcer trial

U.S. patent protects methods of angiogenesis inhibition using Xoma's BPI products

Endothelin antagonists a focus of R&D at Merck KGaA

Three major studies support antiglaucoma efficacy of Cosopt

Anti-H. pylori cephems in development at Takeda

Mercian presents HIV protease inhibitors produced by fungus

Wide series of 5-HT antagonists from Eisai useful as antispastic agents, central muscle relaxants

Agents for nephritis in the Tsumura pipeline

Viagra now on the shelves in U.K. pharmacies

First potent, orally active LHRH antagonist discovered by Takeda

p38 kinase inhibitor RWJ-68354: a promising clinical candidate for inflammatory conditions

Major component of antibiotic complex expected to be useful as an anti-MRSA agent

Safe and effective treatment of acute CHF with nesiritide

ACR attendants learn more about the efficacy and safety of Enbrel in patients with RA, JRA

First oral medication for periodontitis now available in U.S. pharmacies

Increased dose strengths of Raxar now available in single-therapy box

Bayer cleared to acquire Chiron Diagnostics

MPIF advances to phase II trials in cancer patients

FDA Advisory Committee recommends approval of Ligand's Panretin Gel

Inhibitor of selectin-dependent cell adhesion (BMS-184000) evaluated in models of inflammation

Ozagrel hydrochloride effectively prevents development of preeclampsia in pregnant women

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...